Impact Factor
3.27
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
2.43
350 total citations
h5-index
26
h5 depth signal
Cited share
74.8%
113 of 151
Total citations
350
Citation footprint
Metric signal
2.77
External metric anchor
Self-citation
15.1%
53 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
China
167
Brazil
116
United States
106
United Kingdom
64
Italy
53
Citing Fields of Research
Cellular Membrane Transporters & Receptors
572
Immunology
79
Physiology
64
Anesthetic & Pain Medicine
49
Neurodegenerative Disorders
33
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
1,235
Articles tracked across the journal lifetime
Indexed publication set
151
113 cited publications
Last 12 months
77
8.6 publications/month
Open access share
48.1%
37 OA publications in the last year
Leading citing country
China
167 citing publications
Leading citing field
Cellular Membrane Transporters & Receptors
572 citing publications
Latest tracked publication
20 October 2026
10 recent records available
Coverage & Indexing History
v8n1, Mar. 2012-
v1n1, 2004-
Active Coverage
Research Focus & Classification
Indexed Subjects
Cellular Membrane Transporters & Receptors
Broad Categories
Biochemistry
Neurology
Cellular Membrane Transporters & Receptors
MeSH Descriptors
Receptors, Purinergic
Signal Transduction
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
02
DOI 10.1007/s11302-026-10191-1
Open DOI
Targeting the P2X7 receptor in Alzheimer’s disease: mechanistic insights and emerging therapeutic strategies
03
04
DOI 10.1007/s11302-026-10190-2
Open DOI
P2X7 receptor gene polymorphisms in atherosclerosis patients classified based on angiographic stenosis grading
05
DOI 10.1007/s11302-026-10188-w
Open DOI
ATP is not always pro-inflammatory: rethinking purinergic signalling in cancer and autoimmunity
Extracellular adenosine 5′-triphosphate (ATP) has been recognized for many years as a prototypical danger signal that promotes inflammation primarily through activation of purinergic receptors, particularly P2X7. This framework has had a...
06
07
DOI 10.1007/s11302-026-10187-x
Open DOI
ATP-sensing DNA origami nanodevices for targeted modulation of purinergic signaling in inflammatory tissue injury
08
09
DOI 10.1007/s11302-026-10183-1
Open DOI
The role of natural polyphenols in purinergic signaling: from molecular mechanisms to physiological implications
10
DOI 10.1007/s11302-026-10186-y
Open DOI
Soluble P2X7 receptor (sP2X7R) as a marker of inflammation in pregnancy
The purinergic P2X7 receptor (P2X7R) is a key regulator of inflammation and pro-inflammatory cytokine release. Recently, a soluble form of P2X7R (sP2X7R) has been identified in the circulation of healthy individuals and significantly inc...
Bibliographical & Catalog Notes
Description based on: Vol. 2, no. 1 (2006); title from cover.
Print issues ceased with v.7, no. 3 (2011)
Also issued online.